Journey Medical

Journey Medical

DERM
United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

DERM · Stock Price

USD 5.00-1.88 (-27.33%)
Market Cap: $132.6M

Historical price data

Overview

Journey Medical Corporation is a commercial-stage dermatology company with a mission to improve patient well-being by providing effective solutions for treating skin conditions. Its core strategy involves identifying, acquiring, and strategically commercializing innovative, differentiated dermatology products through a lean, experienced commercial team. As a publicly traded subsidiary of Fortress Biotech, the company has built a portfolio of approved products and employs an asset-light, acquisition-driven model to grow within the specialty dermatology market.

DermatologyAcneRosacea

Technology Platform

Journey Medical's platform is its integrated commercial and operational model, consisting of a lean, experienced dermatology-focused team, a targeted sales force, and expertise in managed care, trade, and marketing to rapidly integrate and optimize acquired products.

Pipeline

7
7 drugs in pipeline3 in Phase 3

Funding History

3
Total raised:$45M
IPO$25M
Series A$15M
Seed$5M

Opportunities

The large and growing global dermatology market, particularly in chronic conditions like acne and rosacea, presents a sustained opportunity.
Journey Medical's asset-light, commercial-focused model is well-suited to capitalize on under-commercialized or niche products that larger companies may overlook.

Risk Factors

Growth is heavily dependent on the successful and timely acquisition of new products.
The company also faces significant competition, regulatory risks (especially for products like Accutane with strict REMS), and potential revenue concentration in a small portfolio of brands.

Competitive Landscape

Journey Medical competes with large pharma dermatology divisions, established dermatology biotechs, generic manufacturers, and other commercialization-focused firms. Its primary competitive advantages are its specialized commercial expertise, lean operational model, and focused relationships within the dermatology community.